Two stocks which look to be in process of major turns:
IRSN: Irvine systems: various technologies,(mem tech, advanced sensing, micro gyro, digital film for 35 mm cameras) a number of valuable patents, sales at beginning of cycle. The major thing here is that this company has been a research outfit which did not know how to capitalize on the technologies which they control. Poor management etc. In the last two years have been changing focus. Some of their technologies have large potential, with potential for explosive growth. Note their last press release re: order from supplier, meaning they will have large orders to fill. They do business with 3 com(have some of their tech. in palm pilots) , Boeing, Gov. etc. And beyond the fundamentals the chart is indicating a turn. Could easily achieve very large sales increases. Take a look at their products.
CYTO: Cytogen: Similar history(but different area) to IRSN re management failings. Their drugs have not sold up to expectation, but they do have 3 approved and for sale. The company has undergone a major change. Tightened expenses, new agreements etc. etc. Has MAJOR money in background, and of most interest, a potential blockbuster technology (PSMA) which could drive this company in the future. It is unlikely to drop back below its lows, as the cash flow is increasing.
Check them out. Both could easily be 5 to 10 baggers based on prospects of new tech. and/or increasing sales of existing products. Both charts are indicating major turns.
Eric |
